Chengdu Institute of Biological Products Co.,Ltd. Report issue

Government Phase 2 Phase 4
Founded: Chengdu China (1958)

Organization Overview

First Clinical Trial
2013
NCT02062281
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chengdu Institute of Biological Products Co.,Ltd.